EPIRUBICIN/PACLITAXEL/CARBOPLATIN (TEC) VERSUS PACLITAXEL/CARBOPLATIN (TC) IN FIRST-LINE TREATMENT OF OVARIAN CANCER FIGO STAGES IIB-IV. MATURE RESULTS OF A RANDOMIZED AGO-GINECO GCIG INTERGROUP PHASE III TRIAL